From 1-2-18: Arrayit completes site visit and laboratory tour with a key business-to-business B2B partner and regulatory consultant regarding submission of a proprietary microarray product line to the United States Food and Drug Administration for FDA clearance https://www.fda.gov
From 3-14-18: Arrayit clinical team submits requested standard operating procedures SOPs and other documentation required for submission of a major microarray technology product to the United States Food and Drug Administration FDA for FDA regulatory clearance https://www.fda.gov
From 5-17-18: Arrayit clinical team confirms meeting with the United States Food and Drug Administration FDA to discuss FDA clearance of a major product line. The FDA is headquartered in Silver Spring Maryland USA and improves healthcare by ensuring public safety http://fda.gov
From 5/29/2018 Tweet: Arrayit CLIA clinical team confirms 7/2/2018 meeting with top officials at the United States Food and Drug Administration FDA headquartered in Silver Spring Maryland USA to discuss FDA regulatory clearance of a major microarray technology product line (link: https://www.fda.gov) http://fda.gov
Can you believe Silicon Valley biotech stock ARYC has a market cap under $40m?? Biotech companies have valuations in excess of 50-100 x earnings yet Arrayit is trading at 4x despite having FDA clearance meeting in 3 weeks. RRBB is our auditor and 10k releases could be any day now. I hope you are all seeing how much upside potential this stock has :) Get ready for another huge week, this is just the beginning :) Replies: T-23 days for FDA meeting:)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.